UniSuper Management Pty Ltd cut its holdings in Danaher Co. (NYSE:DHR – Free Report) by 45.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 167,838 shares of the conglomerate’s stock after selling 141,169 shares during the quarter. UniSuper Management Pty Ltd’s holdings in Danaher were worth $38,527,000 at the end of the most recent quarter.
Several other large investors also recently added to or reduced their stakes in the business. Kentucky Retirement Systems Insurance Trust Fund lifted its stake in shares of Danaher by 11.6% in the 4th quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 21,233 shares of the conglomerate’s stock valued at $4,874,000 after purchasing an additional 2,202 shares during the last quarter. ORG Partners LLC lifted its position in shares of Danaher by 1,212.8% in the fourth quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate’s stock worth $636,000 after buying an additional 2,559 shares during the last quarter. Generate Investment Management Ltd bought a new stake in shares of Danaher during the 4th quarter worth about $8,044,000. Stifel Financial Corp increased its holdings in shares of Danaher by 1.3% during the 3rd quarter. Stifel Financial Corp now owns 847,348 shares of the conglomerate’s stock valued at $235,583,000 after acquiring an additional 11,216 shares during the last quarter. Finally, Compass Capital Management Inc. raised its stake in shares of Danaher by 4.8% in the 4th quarter. Compass Capital Management Inc. now owns 237,922 shares of the conglomerate’s stock valued at $54,615,000 after acquiring an additional 10,994 shares in the last quarter. 79.05% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
A number of brokerages have issued reports on DHR. StockNews.com cut Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, December 14th. Barclays decreased their price objective on shares of Danaher from $275.00 to $240.00 and set an “equal weight” rating for the company in a report on Thursday, January 30th. Raymond James reiterated a “market perform” rating on shares of Danaher in a report on Monday, February 3rd. Bank of America upgraded shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price target for the company in a report on Friday, December 13th. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $277.00 price objective (down from $299.00) on shares of Danaher in a research note on Thursday, January 30th. Five equities research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $278.24.
Danaher Stock Performance
NYSE DHR opened at $210.15 on Thursday. Danaher Co. has a twelve month low of $196.80 and a twelve month high of $281.70. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The stock has a market cap of $150.19 billion, a P/E ratio of 39.80, a PEG ratio of 2.66 and a beta of 0.82. The company’s 50-day simple moving average is $215.86 and its 200 day simple moving average is $237.56.
Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period last year, the company posted $2.09 EPS. As a group, research analysts forecast that Danaher Co. will post 7.63 earnings per share for the current fiscal year.
Danaher Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, March 28th. This is a boost from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.61%. Danaher’s dividend payout ratio (DPR) is presently 24.24%.
Insider Activity
In related news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 11.10% of the stock is owned by corporate insiders.
Danaher Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
See Also
- Five stocks we like better than Danaher
- Stock Splits, Do They Really Impact Investors?
- Energy Transfer: Powering Data With Dividends and Diversification
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Qualcomm Stock Is Coiling for a Breakout
- How to Profit From Value Investing
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.